Novel reductant for determination of total plasma homocysteine

Clinical Chemistry

Volumn 43, Issue 4, 1997, Pages 687-688

  Gilfix, Brian M ^a   Blank, David W ^a   Rosenblatt, David S ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE; PHOSPHINE DERIVATIVE; REAGENT; REDUCING AGENT;

AMINO ACID ANALYSIS; AMINO ACID BLOOD LEVEL; ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; CALIBRATION; CHROMATOGRAPHY; HUMAN; QUANTITATIVE ASSAY; REDUCTION;

EID: 0030900736     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.4.687     Document Type: Article

References (5)

1. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 1995;274:1049-57.
2. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 1993;39:1764-79.
3. Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 1987;422:43-52.
4. Ubbink JB, Vermaak WJH. Rapid high-performance liquid Chromatographic assay for total homocysteine levels in human serum. J Chromatogr 1991;565:441-6.
5. Fortin L-J, Genest J Jr. Measurement of homocyst(e)ine in the prediction of atherosclerosis Clin Biochem 1995;28:155-62.